葡萄糖和氧气代谢之间的合关系作为阿尔茨海默病的成像生物标志物
Ze Yang1,2, Jinhua Sheng3,4, Qiao Zhang5,6,7
1School of Computer Science and Technology, Hangzhou Dianzi University, Hangzhou, 310018, Zhejiang, China.
Scientific reports
|May 15, 2025
概括
CD33 rs3865444多态性通过影响微质细胞活动和大脑代谢,影响阿尔茨海默病的风险. 在CC载体中降低的葡萄糖-氧气合介导认知衰退,突出了阿尔茨海默病进展的关键途径.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 阿尔茨海默氏症疾病研究研究
背景情况:
- CD33 rs3865444多态性与阿尔茨海默病 (AD) 风险有关.
- CD33在大脑微质细胞中表达,在认知障碍中表达变化.
- 小等位基因 (A) 是保护性的,减少了CD33表达和粉样β斑块负担.
研究的目的:
- 为了研究CD33 rs3865444多态性在认知障碍中的作用.
- 为了探索这种多态性影响葡萄糖代谢-神经元活动合的假设.
- 确定对认知轨迹和阿尔茨海默病进展的影响.
主要方法:
- 这项研究包括107名患有轻度认知障碍的患者.
- 在边缘轨道前皮层中评估的葡萄糖-氧气 (G/O) 合系数.
- 采用调解分析来检查多形态对认知衰退的影响.
主要成果:
- 在CD33 rs3865444 CC基因型组中,G/O合系数显著降低.
- 调解分析显示,G/O合完全调解了多形态对临床痴呆症的影响.
- 风险等位基因 (C) 与异常的微质激活,神经炎症和增加的代谢水平有关.
结论:
- CD33 rs3865444 多态性影响大脑葡萄糖代谢和神经元活动合.
- 这种受损的合是阿尔茨海默病认知障碍进展的关键因素.
- 向CD33和代谢途径可能为AD提供治疗策略.
相关概念视频
Glucose Transporters
15.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.3K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Glucose Homeostasis: Regulation of Blood Glucose
4.4K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
4.4K
Alzheimer Disease l: Introduction
29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42


